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ABSTRACT
The mammalian ERCC1-XPF endonuclease has a
suggested role in the repair of DNA double-strand
breaks (DSB) by single-strand annealing (SSA).
Here, we investigated the role of ERCC1 in homo-
logous recombination in mammalian cells, and
confirm a role of ERCC1 in SSA. Interestingly,
we also report an unexpected role for ERCC1 in
gene conversion. This provides support that gene
conversion in mammalian somatic cells is carried
out through synthesis-dependent strand annealing,
rather than through a double Holliday Junction
mechanism. Moreover, we find low frequencies of
SSA and gene conversion in G1-arrested cells,
suggesting that SSA is not a frequent DSB repair
pathway in G1-arrested mammalian cells, even in
the presence of perfect repeats. Furthermore,
we find that SSA is not influenced by inhibition of
CDK2 (using Roscovitine), ATM (using Caffeine
and KU55933), Chk1 (using CEP-3891) or DNA-PK
(using NU7026).
INTRODUCTION
The ERCC1 protein exists in a complex with the XPF
endonuclease, which specifically cleaves 30 single-stranded
DNA (ssDNA) flaps of double-stranded DNA (dsDNA)
(1). The mammalian ERCC1/XPF endonuclease functions
in nucleotide excision repair (NER) (1,2), gene targeting
(3) and single-strand annealing (SSA) (4). Although
ERCC1 plays a major role in NER, it was found not to
be associated with the defects in any of the known human
NER disorders, such as Xeroderma pigmentosum (XP),
Cockayne syndrome and Trichothiodystrophy (5–7).
However, a human deficiency in the ERCC1 gene was
recently reported (8) and the patient’s cells showed only
moderate hypersensitivity to UV light and mitomycin C
as compared to XP patients. Surprisingly, the clinical
features of the ERCC1-defective patient were very
severe and were compatible with a diagnosis of cerebro-
oculo-facio-skeletal syndrome. The mild repair defect
and clinical severity suggest novel functions for ERCC1,
in agreement with the observations in ERCC1 knockout
mice, which display severe phenotypes compared to other
NER deficient mouse models, involving multiorgan
failure, severe runting and death before weaning (9–11).
These observations indicate additional roles for the
ERCC1-XPF endonuclease other than its function
in NER.
There is evidence for a role of ERCC1 in homologous
recombination (HR) between direct repeats in the adenine
phosphoribosyltransferase locus in Chinese hamster cells
(12,13). Moreover, ERCC1/XPF was found to be required
for targeted gene replacement via recombination in mouse
embryonic stem cells (14). SSA is an efficient way to repair
2-ended double-strand breaks (DSB) between repeated
sequences (15). SSA requires resected DNA ends, which
are believed to be produced by the Mre11/Rad50/Nbs1
complex (16). The combined function of the RAD52
protein, which binds 30 ssDNA ends, and the RPA
protein, which binds tightly to ssDNA, is believed to be
sufficient to initiate SSA between repeated sequences, e.g.
Alu sequences, in mammalian cells (17–19).
To test the role of ERCC1 in SSA and gene conversion,
we introduced the DRneo recombination reporter
construct into the ERCC1-defective Chinese hamster cell
line UV4, which we then complemented with ERCC1.
A DSB was induced into the reporter construct by trans-
fecting with an I-SceI expression plasmid and SSA
and gene conversion frequencies were determined. We
found reduced levels of both SSA and gene conversion in
ERCC1-defective cells, suggesting that ERCC1 is involved
in both these recombination pathways in mitotic mam-
malian cells. Furthermore, we find lower frequencies
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of SSA in G1-arrested cells, suggesting that this pathway
is not a common complement to non-homologous
end joining (NHEJ) in repair of 2-ended DSBs in
G1-arrested cells.
MATERIALS AND METHODS
Cell lines
The cell lines used are UV4DR7, ERCC1.17, ERCC1.21
and PEF7. The UV4DR7 cell line was created following
electroporation of the DRneo vector and isolation of
individual clones as described earlier (20). To obtain an
ERCC1-complemented UV4DR7 cell line, the ERCC1
gene was cloned into the PEF6-V5-His-Topo vector
according to the manufacturer’s protocol (Invitrogen).
The ERCC1 cDNA was amplified in a two-step RT-PCR
with RNA extracted from SPD8 cells using primers;
ERCC1-f 50-CAG ATG GAC CTT GGG AAA GAC-30
and ERCC1-r 50-TTA TGA CGC TGT AGC CTC
AGC-30. A total of 5 106 cells/ml were electroporated
with 30 mg of pEF6-V5-His-ERCC1 or empty control
vector (1500mF capacity, 250V for 30 s). Blasticidin
(5mg/ml) was added 48 h following electroporation and
individual blasticidin resistant colonies isolated and
expanded. All cell lines were cultured in Dulbecco’s
Modified Eagle’s Medium supplemented with 10% fetal
calf serum, penicillin (60 mg/ml), streptomycin (100mg/ml)
at 378C containing 5% CO2, in a humidified incubator.
The medium was supplemented with hygromycin
(0.05mM) in order to maintain the DRneo vector, and
Blasticidin (3mg/ml) to maintain the PEf6-V5-His-ERCC1
and PEF6-V5-His-Topo vector-containing cell lines.
Southern blotting
Genomic DNA was isolated from the UV4DR7 cell line,
phenol–chloroform treated and digested with restriction
endonucleases. Ten microgram of purified DNA was
digested HindIII, HindIII + SacI, HindIII + KpnI and/or
HindIII + NcoI was used. To determine that only one
integrated copy of DRneo was present in the genome.
The HindIII + XhoI was used to determine the size of
the DRneo substrate in G418R clones. All DNA was
separated by gel electrophoresis and Southern blotting
was carried out as previously described using the S2neo
fragment as probe (20).
UV survival assay
Five hundred cells from each cell line were seeded over
night to be treated with different doses of UV (0, 0.2, 0.5,
1, 2, 5 and 10 J/m2) on the following day. After that they
were incubated for 7–14 days in a humidified 5% CO2/37C
incubator and then the colonies were fixed and stained
with 0.4% methylene blue in methanol and individual
colonies (greater than 30 cells) counted.
Recombination assay
To avoid contamination with spontaneous G418 resistant
clones in the DRneo recombination assay, 103 cells from
each cell lines were separately expanded to confluencency
on about 10 different Petri dishes for each cell line
(Ø 100mm). The spontaneous recombination frequency
was determined for each cell population by selection of
2 105 cells/plate (Ø 100mm) seeded in G418 (100mg/ml).
Only those cell populations that did not retrieve viable
G418R colonies were used for further recombination
assays, as they have low background frequency of
spontaneous G418R cells.
In the recombination assay, 1.5 106 cells of each
cell line (UV4DR7, ERCC1.17, ERCC1.21 and PEF7)
were seeded over night, and transiently trans-
fected with or without pCMV3xnls-I-SceI expression
vector (100 ng) according to manufacturer’s protocol
(Lipofectamine2000TM, Invitrogen, UK, final DNA con-
centration 10 mg/ml) to create DSBs. After 5 h of incuba-
tion in the humidified 5% CO2/378C incubator, cells were
changed to complete medium. Twenty-four hours after
transfection, the cells were trypsinized and counted. For
recombination frequency, 2 105 cells/plate (Ø 100mm)
were seeded and G418 (100mg/ml) and/or hygromycin
(0.5mg/ml) were added for selection to both treated and
untreated plates. A total of 500 cells/plate were seeded
to determine the cloning efficiency. Plates were incubated
for 7 or 10 days for cloning and selection, respectively,
after which they were fixed and stained with 0.4%
methylene blue in methanol.
For synchronization of cells in G1 phase of the cell
cycle, we plated 1.5 106 ERCC1.17 and 2.5 106
UV4DR7 cells for 48 h to reach contact inhibition,
or 2 106 ERCC1.17 and UV4DR7 cells were grown for
48 h in serum-free media. Cells were then transiently
transfected with either pCMV3xnls-I-SceI or pEGFP-C2
vectors and then followed the above protocol for cloning
and selection, or treated with inhibitors throughout
the transfection with 2mM caffeine, 10 mM KU55933,
10 mM NU7026, 25 mM Roscovitine or 500 nM CEP-3891.
All experiments were repeated independently at least
three times.
FACS analysis
To determine lipofectamin transfection rates, cells were
transiently transfected with a reporter vector, pEGFP-C2
Vector (Invitrogen), using the manufacturer’s
protocol (Invitrogen) and expression of EGFP was
analysed by FACS Sort Vantage (Becton Dickinson, UK).
For cell cycle analysis, arrested cells were harvested,
washed twice in PBS and fixed in 70% cold ethanol
followed by treatment with 1mg/ml RnaseA and staining
with 100mg/ml propidium iodide. The proportion of
arrested cells in each phase of cell cycle was then
determined by FACS Sort Vantage.
Western blotting
A total of 2 106 cells was plated onto 100mm dishes
and grown for 24 h. Cells were then lysed in RIPA
buffer (1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS
and 0.1mM PMSF in PBS) in the presence of 1 protease
and phosphatase inhibitor cocktails (Sigma, UK).
An aliquot of 50 mg total protein was then run on a 10%
SDS–PAGE gel and transferred to Hybond C membrane
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(Amersham Pharmacia, UK) using a semi-dry transfer cell
(Bio-Rad). This membrane was blocked in 5% milk for 1 h
and immunoblotted with mouse monoclonal antibody
ERCC1 vAb-2 (clone 8F1; Labvision), diluted 1:200 in
5% milk in PBS-0.05% Tween and rabbit anti-actin
(Sigma) antibody diluted 1:2000 in 5% milk in PBS-0.05%
Tween overnight. Anti-mouse peroxidase conjugate
(Sigma 1:2000) and anti-rabbit peroxidase conjugate
(Cell Signaling 1:1000) were used, respectively, as second-
ary antibodies and immunoreactive protein was visualized
using ECL reagents (Amersham Pharmacia) following
manufacturer’s instructions.
RESULTS
ERCC1 is involved in SSA and gene conversion
Here, we studied the role of ERCC1 using a recombina-
tion reporter construct, DRneo (21), which contains
a hygromycin (Hyg) resistance gene and two non-
functional copies of the neoR gene. After introduction of
a DSB, these non-functional copies revert to a functional
neoR gene through either SSA, sister chromatid exchange
(SCE) or gene conversion, conferring resistance to
geneticin (G418) (Figure 1A). We first stably integrated
the DRneo reporter construct into the genome of the UV4
hamster cell line that is deficient in ERCC1 (1), and
isolated individual hygromycin-resistant clones. The pre-
sence and correct integration of a single DRneo copy into
the UV4DR7 clone was confirmed using Southern blotting
with S2neo as probe (Figure 1B). HindIII cleavage
resulted in a single 6.5 kb band, showing that the DRneo
construct is present in one copy (Figure 1B). HindIII and
KpnI or SacI cleavage gave the same 6.5 kb band, which
implies that KpnI and SacI cleave outside the 6.5 kb
region. HindIII and NcoI cleavage produced a 4.7 kb and
a 1.4 kb band, showing that the internal structure of
DRneo is preserved in the UV4DR7 clone.
The pCMV3xnlsI-SceI vector was transiently trans-
fected into UV4DR7 cells to express the I-SceI endo-
nuclease to induce a DSB in the DRneo substrate. We
performed a fluctuation assay to determine the extent of
recombination induced and found that a DSB induces HR
103-fold (Figure 1C). This shows that ERCC1-defective
cells have no overall defect in HR.
We transfected the UV4DR7 cell line with the
pEF6-V5-His vector containing the hamster ERCC1
gene, or with the empty control vector. Individual clones
were isolated and the level of ERCC1 expression quanti-
fied by western blotting, using extracts from hamster
AA8 and human HeLa cells as control (Figure 2A).
The ERCC1.17 and ERCC1.21 clones expressed ERCC1
to the same extent as wild-type hamster AA8 cells and
fully complemented the sensitivity of ERCC1-defective
cells to UV treatments (Figure 2B). In contrast, the clone
PEF7 containing the empty control vector was still
sensitive to UV as a result of the continued defect in
ERCC1. The reason for the slight UV sensitivity difference
to UV4DR7 is likely explained by that PEF7 the fact is an
isolated clone from UV4DR7.
We investigated HR in the UV4DR7, ERCC1.17,
ERCC1.21 and PEF.7 cell lines by transiently transfecting
the cells with pCMV3xnlsI-SceI vector to create a DSB
in the S2neo fragment of the DRneo reporter construct.
Recombination of DRneo to a neoR gene can occur
through either gene conversion, SSA or SCE (Figure 1A).
If the neoR gene is restored by gene conversion, the hygR
gene in between the repeats will be retained, while it will
be lost following SSA or SCE (Figure 1A). We selected
recombinant clones with G418 or G418 plus hygromycin
(G418 + Hyg) to determine the frequency of the different
recombination events.
If ERCC1 is exclusively involved in SSA, it would be
expected that the levels of G418 resistant, but not G418 +
Hyg resistant, clones would be lower in UV4DR7 and
PEF7 cells, as those represent the products of SSA.
Surprisingly, both the levels of G418 and G418 + Hyg
resistant recombinants were reduced in UV4DR7 and
PEF7 cells (Figure 2C). The levels of SSA and gene
conversion were reduced by 83% and 75% in ERCC1-
defective cells, respectively. These data demonstrate that
ERCC1 is involved not only in SSA, but also in gene
conversion.
We isolated 10 G418-resistant clones and determined
the recombination products using Southern blotting and
compared the results to their subsequent resistance to
hygromycin (Figure 2D). The presence of a 4.0 kb band
in the Southern blots correlated with hygromycin resis-
tance. Interestingly, we found a clone with both the
1.1 and 4.0 kb bands, indicating that two DRneo alleles
(present after replication) reverted to neoR genes using
different mechanisms, which has been reported earlier for
a similar recombination substrate (20,22). Altogether,
these data show that G418 + Hyg resistance correlates
with a gene conversion recombination product, which
has also been shown to be the case with the same recom-
bination reported earlier (21).
Suppressed SSA in G1-arrested cells
It is well established that HR predominates during and
following replication and that NHEJ predominates in the
G1 phase of the cell cycle (23,24). As SSA is generally
believed to occur also in the absence of a sister chromatid,
it is plausible that this could be a frequently used pathway
for DSB repair in G1-arrested cells, as a complement
to NHEJ. We had the DRneo substrate present in both
ERCC1-defective and complemented cells, allowing us
to test if SSA is specifically used for DSB repair in
G1-arrested cells. We synchronized cells in the G1 phase
using either serum starvation (SFM) or contact inhibition
(CI) (by growing cells to confluency). We found that a
48-h SFM or CI of UV4DR7 or ERCC1.17 cells
accumulated in the G1 phase (Figure 3A). The cells were
subsequently transfected with the pCMV3xnlsI-SceI
vector for 5 h and kept arrested for an additional 19 h,
to ensure expression of the I-SceI restriction endonuclease
and DSB formation while cells were still in the G1 phase,
before replating for selection in G418 or G418 + Hyg.
We have previously reported differential transfection
efficiency between cycling and arrested cells (24).
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Thus, to compensate for differential effects in expression
from the pCMV3xnlsI-SceI, we co-transfected cells with
the same amount of pEGFP-C2 vector, expressing the
green fluorescent protein (GFP) from the same CMV
promoter as the one expressed in the pCMV3xnlsI-SceI
vector. We found reduced GFP expression in G1-arrested
cells (data not shown), in agreement with the previously
published results (24). We determined the I-SceI-induced
recombination frequencies in G1-arrested and cycling cells
and compensated the recombination frequency of the
arrested cells for the reduced transfection efficiency.
In ERCC1 expressing wild-type cells, we found that
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Figure 1. Homologous recombination is induced >100-fold by a single DSB in ERCC1-defective UV4DR7 cells. (A) Structure of the DRneo
recombination substrate containing two non-functional copies of the neoR gene. A functional neoR gene can be produced by SSA, SCE or gene
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least three experiments is depicted.
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both the levels of gene conversion and SSA drop in
G1-arrested cells. The gene conversion level (represented
by the yellow bar) dropped 2-and 4-fold in serum-starved
ERCC1.17 and ERCC1.21 cells, respectively and 3-fold in
both cell lines that were contact-inhibited (Figure 3B),
in agreement with our earlier report that gene conversion
events are reduced in G1-arrested cells (24).
Interestingly, the SSA levels in ERCC1 proficient cells
(represented by blue bar minus yellow bar) dropped 5- to
6-fold in both serum-starved and contact-inhibited cells as
compared to dividing control cells (statistically significant
P< 0.001). Thus, the efficiency of SSA, even within perfect
repeats, is reduced in G1-arrested cells.
The reduction of gene conversion and SSA was not as
profound in ERCC1-defective UV4DR7 and PEF7 cells.
These data suggest that ERCC1-dependent SSA and gene
conversion are more efficient in cycling cells and that
ERCC1-independent recombination events contribute to
the recombination events that restore a functional neoR
gene in G1-arrested cells. Overall, our data suggest that
ERCC1-dependent SSA and gene conversion is more
efficient following replication in the S/G2 phase of the
cell cycle.
SSA is independent of cell cycle checkpoint signalling
It was reported earlier that HR repair of a DSB depends
on the checkpoint proteins Ataxia-Telangiectasia and
Rad3-related (ATR) and Chk1 (25), and that resection
of DNA ends to facilitate ATR activation and HR relies
on cyclin-dependent kinases (CDK) activity (26–28).
Thus, one reason for reduced SSA in G1-arrested cells
could be the absence of CDK activity in these cells and
thus a reduced resection at DSBs. Absence of resection is
likely to prevent SSA as no ssDNA homologies would be
unveiled. To test the possibility that SSA depends on cell
cycle checkpoint signalling, we used various protein kinase
inhibitors; Roscovitine inhibits CDK especially CDK2,
which plays an essential role in initiating replication (29).
Caffeine is a broad range phosphoinositide 3-kinase
related kinase inhibitor, inhibiting both ATM (Ataxia-
Telangiectasia Mutated) and ATR (30). KU55933 is a
specific ATM inhibitor and NU7026 inhibits the DNA-
dependent protein kinase (DNA-PK) required for NHEJ
(31). CEP-3891 is a specific inhibitor of Chk1 (25).
We treated ERCC1.17 cells with the inhibitors during
transfection of the pCMV3xnlsI-SceI vector and during
the 24 h recovery period before re-plating with selection
with G418 or G418 + Hyg. We found no differences
in either gene conversion or SSA levels in the presence of
any of the inhibitors (Figure 4). No differences in gene
conversion or SSA levels were found in the UV4DR7 cell
line (data not shown). Others and we have previously
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Figure 2. ERCC1 is involved in SSA and gene conversion. (A) Western
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reported that HR is indeed inhibited by caffeine, KU55933
and CEP-3891 (25,32,33), using other recombination
reporter substrates. The difference in these reporter sub-
strates is that they require strand invasion to recover
a neoR gene, and thus SSA does not produce a neoR gene.
Overall, our data does not support a role for checkpoint
signalling in SSA.
DISCUSSION
Here, we investigate the role of ERCC1 in HR using
established ERCC1-defective hamster cells (1,34). The
ERCC1 protein partners with the XPF endonuclease, and
together they act as a heterodimer (35,36). Thus, we are
essentially studying the role of the ERCC1/XPF endo-
nuclease in HR. However, it is important to point out
that disease connected with an ERCC1 mutation is much
more severe than those with XPF mutation (8). Thus, the
effects seen here might also be unrelated to XPF. Previ-
ously, it was established that ERCC1 has an important
role in SSA, interstrand cross-link repair as well as in
gene targeting (3,12,37–40). Here, we confirm the role of
ERCC1 in SSA and find almost 10-fold reduced levels
of SSA in ERCC1-defective cells.
In spite of the SSA defect in ERCC1-defective cells, it is
important to note that our results show that HR between
repeated sequences is induced >100-fold by a DSB even in
absence of ERCC1 (Figure 1C). Thus, there are likely
other endonucleases that can compensate for the loss of
ERCC1. The recombination reporter used here cannot
distinguish between an SSA and SCE event. However,
it has been shown earlier that SCEs are very rare products
of the repair of 2-ended DSBs produced by I-SceI (20–22).
Thus, the 10-fold reduction in recombination rates likely
corresponds to a defect in SSA.
Interestingly, we also find a defect in gene conversion
in ERCC1-defective cells. This implicates a role for the
ERCC1/XPF endonuclease in gene conversion repair of
a 2-ended DSB. Currently, there are two different models
suggested for repair of a 2-ended DSB, the double-
Holliday Junction (HJ) model (41) and the synthesis-
dependent strand annealing (SDSA) model (42). The
strand invasion in the SDSA model is reversed, once
repair synthesis has progressed beyond the initial break-
point and the repair is carried out in an SSA step
(Figure 5). As the ERCC1/XPF endonuclease is required
for efficient SSA, it is expected that the same complex also
would carry out cleavage of non-homologous 30 ends
produced also in this model. Thus, our data support the
SDSA model for repair of 2-ended DSBs in favour of
the double-HJ model as the ERCC1/XPF is likely not
a HJ resolvase (43,44). A D-loop nicking model for DSB
repair has recently been proposed for meiotic recombina-
tion (45). The ERCC1/XPF complex may be an important
mediator at several steps in such a pathway (Figure 5),
but it is unexplored whether this pathway would be
applicable for 2-ended DSB repair in mitosis.
It has been argued that SSA, as opposed to homologous
recombination, is independent of the cell cycle stage
as only a single DNA molecule is used and the sister
chromatid is expendable. Here, we find that the level of
SSA is reduced 3-fold in G1-arrested cells, which does not
support a role for SSA in the G1 phase of the cell cycle.
We find a 3-fold reduction in SSA in spite of the fact that
perfect repeat sequences are available for repair. There are
only limited repeat sequences present in mammalian cells
(46) and thus the actual SSA levels in G1-arrested cells are
probably even lower than we report here.
Here, we wanted to determine what could be respon-
sible for the suppression of SSA in the G1 phase of the cell
cycle. It has been reported earlier that resection at a DSB
depends on CDK activity (26–28) and that HR depends
on ATM (47) and Chk1 signalling (25). Resection at
a DNA end is required for SSA and thus we wanted to
test if SSA depends on any of the CDK2, ATM, Chk1
or DNA-PK kinases. Although all inhibitors were used
at concentrations that inhibit these enzymes in the
same cell type (25,31), we found no effect on the levels
of SSA. Overall, this suggests that CDK2, ATM, Chk1 or
DNA-PK are not involved in SSA or alternatively that the
single DSB produced by the I-SceI endonuclease is not
+ − + − + − + − + − + −
+ − + − + − + − + − + −
co
n
tro
l
co
n
tro
l
Ca
ffe
in
e
Ca
ffe
in
e
KU
55
93
3
KU
55
93
3
N
U7
02
6
N
U7
02
6
R
os
co
vi
tin
e
R
os
co
vi
tin
e
CE
P-
38
91
CE
P-
38
91
I-SceI
10−2
10−3
10−4
10−5
10−2
10−3
10−4
10−5
H
om
ol
og
ou
s 
re
co
m
bi
na
tio
n
(fr
eq
ue
nc
y o
f G
41
8R
 c
lo
ne
s)
H
om
ol
og
ou
s 
re
co
m
bi
na
tio
n
(fr
eq
ue
nc
y o
f G
41
8R
 +
 H
yg
R
 c
lo
ne
s)
co
n
tro
l
co
n
tro
l
Ca
ffe
in
e
Ca
ffe
in
e
KU
55
93
3
KU
55
93
3
N
U7
02
6
N
IU
70
26
R
os
co
vi
tin
e
R
os
co
vi
tin
e
CE
P-
38
91
CE
P-
38
91
I-SceI
A
B
Figure 4. SSA of a single DSB is independent of inhibition of ATM,
DNA-PK, CDK and Chk1 activity. Homologous recombination
induced by an I-SceI-induced DSB in the DRneo construct in the
ERCC1.17 cell line, co-treated with 2mM caffeine, 10 mM KU55933,
10 mM NU7026, 25 mM Roscovitine or 500 nM CEP-3891 throughout
transfections and 24 h recovery period prior to the recombination
assay, using selection with (A) G418 alone (gene conversion + SSA) or
(B) G418+Hyg (gene conversion only). The average and standard
deviation of at least three experiments is depicted.
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sufficient to trigger a checkpoint response that activates
DNA damage signalling.
In conclusion, we show that the ERCC1/XPF endo-
nuclease is involved in both SSA and gene conversion in
mammalian cells, which favours the SDSA model for
repair of 2-ended DSBs. We find that SSA is suppressed
in the G1 phase of the cell cycle and that SSA of a single
DSB occurs efficiently also in presence of inhibitors of cell
cycle checkpoints and DNA repair.
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